Mitotech
Manufacturing · Luxembourg · 51-200 Employees
View Company Info for Free
Overview
Headquarters
43 Ave Jfk, Luxembourg, L-1855, Luxembou...Phone Number
+352 271127060Website
www.mitotechpharma.comRevenue
$10.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Mitotech
Mitotech is focused on empowering mitochondria to improve patients' lives by developing small molecules that protect against mitochondrial dysfunction and enhance energy expenditure. Their innovative approach addresses oxidative stress, which is linked to various diseases, including neurodegenerative disorders, metabolic conditions, autoimmune, and cardiovascular diseases. The company aims to restore mitochondrial function and provide new therapeutic options for a range of health issues. Mitotech's intended clients include patients suffering from rare mitochondrial or metabolic disorders and other related health conditions.Explore more
Mitotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mitotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Mitotech is spiking on competitors!
Click to see if Mitotech had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Mitotech has new funding data
Product Launch: Get notified when Mitotech launches new products
Mitotech, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Mitotech has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Mitotech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Mitotech
Recommended Actions
Find VP level buyers at Mitotech
Find more new buyers
Company Profile Activity
Activity Insights
Mitotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mitotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mitotech.
Mitotech Tech Stack
A closer look at the technologies used by Mitotech
Mitotech News & Media
Essex Biotechnology Secures Exclusive Global Rights and Interests of SkQ1 in the field Ophthalmology from Mitotech
HONG KONG, Oct 13, 2022 - (ACN Newswire) - Essex Bio-Technology Limited (the "Company", together with its subsidiaries, the "Group") wishes to announce that Essex Bio-Investment Limited ("Essex Bio-Investment"), a wholly-owned subsidiary of the Group has on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent assignment deed (together as the "Agreements") in relation to SkQ1 , an active pharmaceutical ingredient, from Mitotech S.A. ("Mitotech"), in
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mitotech
Sign Up For FreeTo access detailed company insights
Mitotech is focused on empowering mitochondria to improve patients' lives by developing small molecules that protect against mitochondrial dysfunction and enhance energy expenditure. Their innovative approach addresses oxidative stress, which is linked to various diseases, including neurodegenerative disorders, metabolic conditions, autoimmune, and... Read More
